Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders

European Journal of Pharmacology

Volumn 711, Issue 1-3, 2013, Pages 57-62

  Mahalwar, Rajkiran ^a   Khanna, Deepa ^a  

^a Rajendra Institute of Technology and Sciences   (India)

Author keywords

Antioxidant enzymes; Cardiovascular disorder; NADPH oxidase; Oxidative stress; Rosuvastatin

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSUVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HYDROPHILICITY; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT RESPONSE; UPREGULATION;

EID: 84878161539     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.04.025     Document Type: Review

References (88)

1. T. Adachi, D.R. Pimentel, T. Heibeck, X. Hou, Y.J. Lee, B. Jiang, Y. Ido, and R.A. Cohen S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells J. Biol. Chem. 279 2004 29857 29862 (Pubitemid 38915870)
2. S. Arora, R. Vaishya, P.K. Dabla, and B. Singh NADPH oxidases in coronary artery disease Adv. Clin. Chem. 50 2010 65 86
3. M.D. Bagatini, C.C. Martins, V. Battisti, D. Gasparetto, C.S. da Rosa, R.M. Spanevello, M. Ahmed, R. Schmatz, M.R. Schetinger, and V.M. Morsch Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction Heart Vessels 26 2011 55 63
4. P. Balakumar, and N. Mahadevan Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword? Br. J. Pharmacol 165 2012 373 379
5. P. Balakumar, S. Kathuria, G. Taneja, S. Kalra, and N. Mahadevan Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? J. Mol. Cell. Cardiol 52 2012 83 92
6. S.W. Ballinger, C. Patterson, C.N. Yan, R. Doan, D.L. Burow, C.G. Young, F.M. Yakes, B. Van Houten, C.A. Ballinger, B.A. Freeman, and M.S. Runge Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells Circ. Res. 86 2000 960 966 (Pubitemid 30324308)
7. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, and A.M. Shah Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 2002 293 296 (Pubitemid 34106175)
8. E. Birben, U.M. Sahiner, C. Sackesen, S. Erzurum, and O. Kalayci Oxidative stress and antioxidant defense World Allergy Organ J. 5 2012 09 19
9. A. Blair, P.W. Shaul, I.S. Yuhanna, P.A. Conrad, and E.J. Smart Oxidised low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation J. Biol. Chem. 274 1999 32512 32519
10. O. Blokhina, E. Virolainen, and K.V. Fagerstedt Antioxidants, oxidative damage and oxygen deprivation stress: a review Ann. Bot. 91 2003 179 194
11. R. Colucci, M. Fornai, E. Duranti, L. Antonioli, I. Rugani, F. Aydinoglu, C. Ippolito, C. Segnani, N. Bernardini, S. Taddei, C. Blandizzi, and A. Virdis Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NaD(P)H oxidase and cyclooxygenase-1 Br. J. Pharmacol 2012 10.1111/j.1476-5381. 2012.02106.x
12. A. Daiber, T. Münzel, and T. Gori Organic nitrates and nitrate tolerance - state of the art and future developments Adv. Pharmacol. 60 2010 177 227
13. J. Davignon The cardioprotective effects of statins Curr. Atheroscler. Rep 6 2004 27 35 (Pubitemid 38898907)
14. N.S. Dhalla, R.M. Temsah, and T. Netticadan Role of oxidative stress in cardiovascular diseases J. Hypertens. 18 2000 655 673 (Pubitemid 30406736)
15. S.P. Didion, M.J. Ryan, L.A. Didion, P.E. Fegan, C.D. Sigmund, and F.M. Faraci Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice Circ. Res. 91 2002 938 944 (Pubitemid 35373594)
16. S. Dikalov, K.K. Griendling, and D.G. Harrison Measurement of reactive oxygen species in cardiovascular studies Hypertension 49 2007 717 727 (Pubitemid 351688335)
17. B. Erdos, J.A. Snipes, C.D. Tulbert, P. Katakam, A.W. Miller, and D.W. Busija Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production Am. J. Physiol. Heart Circ. Physiol. 290 2006 1264 1270
18. X. Fang, N.L. Weintraub, C.D. Rios, D.A. Chappell, R.M. Zwacka, J.F. Engelhardt, L.W. Oberley, T. Yan, D.D. Heistad, and A.A. Spector Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells Circ. Res. 82 1998 1289 1297 (Pubitemid 28294748)
19. F.M. Faraci, and S.P. Didion Vascular protection: superoxide dismutase isoforms in the vessel wall Arterioscler. Thromb. Vasc. Biol. 24 2004 1367 1373 (Pubitemid 39050427)
20. U. Forstermann, and H. Li Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling Br. J. Pharmacol. 164 2011 213 223
21. J. Fujii, and N. Taniguchi Downregulation of superoxide dismutases and glutathione peroxidase by reactive oxygen and nitrogen species Free Radic. Res 31 1999 301 308 (Pubitemid 29452855)
22. S. Fukushima, S.R. Coppen, A. Varela-Carver, G. Brindley, K. Yamahara, P. Sarathchandra, M.H. Yacoub, and K. Suzuki Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration Cardiovasc. Res. 69 2006 459 465 (Pubitemid 43098802)
23. M. Genestra Oxyl radicals, redox-sensitive signaling cascades and antioxidants Cell. Signal. 19 2007 1807 1819 (Pubitemid 47090178)
24. K.F. Gey Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease Br. Med. Bull. 49 1993 679 699 (Pubitemid 23243839)
25. A. Gómez-García, G. Martínez Torres, L.E. Ortega-Pierres, E. Rodríguez-Ayala, and C. Alvarez-Aguilar Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia Rev. Esp. Cardiol. 60 2007 1242 1249 (Pubitemid 350294323)
26. N. Grosser, K. Erdmann, A. Hemmerle, G. Berndt, U. Hinkelmann, G. Smith, and H. Schroder Rosuvastatin upregulates the antioxidant defense protein hemeoxygenease-1 Biochem. Biophys. Res. Commun. 325 2004 871 876 (Pubitemid 39487953)
27. J. Habibi, A. Whaley-Connell, M.A. Qazi, MR. Hayden, S.A. Cooper, A. Tramontano, J. Thyfault, C. Stump, C. Ferrario, R. Muniyappa, and J.R. Sowers Rosuvastatin a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats Endocrinology 148 2007 2181 2188 (Pubitemid 46997071)
28. B. Halliwell, K. Zhao, and M. Whiteman Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies Free Radic. Res. 31 1999 651 669
29. I.R. Hanna, Y. Taniyama, K. Szöcs, P. Rocic, and K.K. Griendling NAD(P)H oxidase- derived reactive oxygen species as mediators of angiotensin II signaling Antioxidant Redox Signal 4 2002 899 914 (Pubitemid 36042466)
30. S.P. Jone, M.F. Gibson, D.M. Rimmer 3rd, T.M. Gibson, B.R. Sharp, and D.J. Lefer Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor J. Am. Coll. Cardiol. 40 2002 1172 1178
31. B.Y. Kang, and J.L. Mehta Rosuvastatin attenuates Ang II-mediated cardiomyocytes hypertrophy via inhibition of LOX-1 J. Cardiovasc. Pharmacol. Ther. 14 2009 283 291
32. N.K. Kapur, and K. Musunuru Clinical efficacy and safety of statins in managing Cardiovascular risk Vasc. Health Risk. Manag 4 2008 341 353 (Pubitemid 351711963)
33. S. Kathuria, N. Mahadevan, and P. Balakumar Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities Mol. Cell Biochem. 374 2013 61 72
34. N. Kuzkaya, N. Weissmann, D.G. Harrison, and S. Dikalov Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase J. Biol. Chem. 278 2003 22546 22554 (Pubitemid 36830310)
35. V. Lahera, M. Goicoechea, S.G. de Vinuesa, M. Miana, N. de las Heras, V. Cachofeiro, and J. Luño Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins Curr. Med. Chem. 14 2007 243 248 (Pubitemid 46043919)
36. P. Lakkisto, E. Palojoki, T. Bäcklund, A. Saraste, I. Tikkanen, L.M. Voipio-Pulkki, and K. Pulkki Expression of heme oxygenase-1 in response to myocardial infarction in rats J. Mol. Cell. Cardiol. 34 2002 1357 1365 (Pubitemid 35244413)
37. U. Laufs, K. Gertz, U. Dirnagl, M. Bohm, G. Nickenig, and M. Endres Rosuvastatin, HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice Brain Res. 942 2002 23 30 (Pubitemid 34597065)
38. H. Li, and U. Förstermann Prevention of atherosclerosis by interference with the vascular nitric oxide system Curr. Pharm. Des 15 2009 3133 3145
39. J.M. Li, N.P. Gall, D.J. Grieve, M. Chen, and A.M. Shah Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 2002 477 484
40. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu. Rev. Pharmacol. Toxicol. 45 2005 89 118 (Pubitemid 40261799)
41. J.K Liao, W.S. Shin, W.Y. Lee, and S.L. Clark Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase J. Biol. Chem. 270 1995 319 324
42. A. Likidlilid, N. Patchanans, T. Peerapatdit, and C. Sriratanasathavorn Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients J. Med. Assoc. Thai. 93 2010 682 693
43. V. Lobo, A. Patil, A. Phatak, and N. Chandra Free radicals, antioxidants and Functional foods: Impact on human health Pharmacogn. Rev 4 2010 118 126
44. A.V. Maksimenko, and A.V. Vavaev Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzymes antioxidants: The next stage of pharmacological counterwork to the oxidative stress. Heart Int. 7 2012 e3 10.4081/hi.2012.e3
45. C. Manrique, G. Lastra, J. Habibi, Y. Wei, E.M. Morris, C.S. Stump, and J.R. Sowers Methods of evaluation of cardiovascular renin angiotensin aldosterone activation and oxidative stress Methods Mol. Med 139 2007 163 179
46. N. Mariappan, C.M. Elks, M. Haque, and J. Francis Interaction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in rats PLoS One 7 2012 e46568 10.1371/journal.pone.0046568
47. R. Mazor, R. Shurtz-Swirski, R. Farah, B. Kristal, G. Shapiro, F. Dorlechter, M. Cohen-Mazor, E. Meilin, S. Tamara, and S. Sela Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients Atherosclerosis 197 2008 937 943 (Pubitemid 351417898)
48. H. Morawietz LOX-1 and atherosclerosis: proof of concept of LOX-1 knockout mice Circ. Res 100 2007 1534 1536 (Pubitemid 46897254)
49. R. Niesner, P. Narang, H. Spiecker, V. Andresen, K.H. Gericke, and M. Gunzer Selective detection of NADPH oxidase in polymorphonuclear cells by means of NAD(P)H-based fluorescence lifetime imaging J. Biophys. 2008 2008 602639 10.1155/2008/602639
50. V.B. O′Donnell, and B.A. Freeman Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease Circ. Res. 88 2001 12 21 (Pubitemid 32064077)
51. A. Otto, D. Fontaine, J. Fontaine, and G. Berkenboom Rosuvastatin treatment protects against nitrate-induced oxidative stress J. Cardiovasc. Pharmacol. 46 2005 177 184 (Pubitemid 41060210)
52. A. Otto, J. Fontaine, E. Tschirhart, D. Fontaine, and G. Berkenboom Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway Br. J. Pharmacol. 148 2006 544 552 (Pubitemid 43882091)
53. T.M. Paravicini, and R.M. Touyz NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities Diabetes Care 2 2008 170 180
54. L. Piconi, M. Corgnali, R. Da Ros, R. Assaloni, T. Piliego, and A. Ceriello The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose J. Diabetes Complications 22 2008 38 45
55. P. Pignatelli, R. Carnevale, S. Di Santo, S. Bartimoccia, C. Nocella, T. Vicario, L. Loffredo, F. Angelico, and F. Violi Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation Biochem. Pharmacol. 84 2012 1635 1642
56. M. Pirro, G. Schillaci, M.R. Mannarino, G. Savarese, G. Vaudo, D. Siepi, R. Paltriccia, and E. Mannarino Effect of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia Nutr. Metab. Cardiovasc. Dis. 17 2007 436 441 (Pubitemid 47079109)
57. W.A. Pryor, and G.L. Squadrito The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide Am. J. Physiol. 268 1995 699 722
58. U. Resch, F. Tatzber, A. Budinsky, and H. Sinzinger Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy Br. J. Clin. Pharmacol. 61 2006 262 274 (Pubitemid 43382625)
59. N.D. Roe, and J. Ren Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases Vascul. Pharmacol 57 2012 168 172
60. R.S. Rosenson Rosuvastatin: a new inhibitor of HMG-CoA reductase for the treatment of dyslipidemia Expert Rev. Cardiovasc. Ther. 1 2003 495 505
61. B. Sadowitz, K. Seymour, M.J. Costanza, and V. Gahtan Basic science review section: statin therapy - Part II: clinical considerations for cardiovascular disease Vasc. Endovascular Surg. 44 2010 421 433
62. A. Schäfer, D. Fraccarollo, M. Eigenthaler, P. Tas, A. Firnschild, S. Frantz, G. Ertl, and J. Bauersachs Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability Arterioscler. Thromb. Vasc. Biol. 25 2005 1071 1077 (Pubitemid 40627857)
63. N. Schupp, U. Schmid, A. Heidland, and H. Stopper Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis Atherosclerosis 199 2008 278 287
64. P. Sicard, B. Lauzier, A. Oudot, D. Busseuil, B. Collin, L. Duvillard, D. Moreau, C. Vergely, and L. Rochette A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats Arch. Mal. Coeur. Vaiss. 98 2005 804 808
65. P. Sicard, N. Acar, S. Gregoire, B. Lauzier, A.M. Bron, C. Creuzot-Garcher, L. Bretillon, C. Vergely, and L. Rochette Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats Br. J. Pharmacol. 151 2007 979 986 (Pubitemid 47195537)
66. P.K. Singal, N. Khaper, V. Palace, and D. Kumar The role of oxidative stress in the genesis of heart disease Cardiovasc. Res. 40 1998 426 432 (Pubitemid 28557280)
67. D. Sorescu, and K.K. Griendling Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure Congest. Heart Fail. 8 2002 132 140 (Pubitemid 34669892)
68. D. Sorescu, D. Weiss, B. Lasseque, R.E. Clempus, K. Szöcs, G.P. Sorescu, L. Valppu, M.T. Quinn, J.D. Lambeth, J.D. Veqa, W.R. Taylor, and K.K. Griending Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 105 2002 1429 1435 (Pubitemid 34263273)
69. R. Stocker, and M.A. Perrella Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation 114 2006 2178 2189 (Pubitemid 44747899)
70. L.L. Stoll, M.L. McCormick, G.M. Denning, and N.L. Weintraub Antioxidant effects of statins Drugs Today (Barc) 40 2004 975 990
71. M. Takemoto, and J.K. Liao Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors Arterioscler. Thromb. Vasc. Biol. 21 2001 1712 1719 (Pubitemid 34219772)
72. M. Tanaka, G.K. Mokhtari, R.D. Terry, L.B. Balsam, K.H. Lee, T. Kofidis, P.S. Tsao, and R.C. Robbins Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts Circulation 110 2004 200 206
73. X.Y. Tian, W.T. Wong, A. Xu, Z.Y. Chen, Y. Lu, L.M. Liu, V.W. Lee, C.W. Lau, X. Yao, and Y Huang Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress Br. J. Pharmacol. 164 2011 598 606
74. D. Tousoulis, N. Papageorgiou, A. Briasoulis, E. Androulakis, M. Charakida, E. Tsiamis, and C. Stefanadis Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies Heart Fail. Rev. 17 2012 65 79
75. R.M. Touyz Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44 2004 248 252 (Pubitemid 39167216)
76. M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser Free physiological functions and human disease Int. J. Biochem. Cell. Biol. 39 2007 44 84
77. K.M. Venardos, A. Perkins, J. Headrick, and D.M. Kaye Myocardial ischemia- reperfusion injury, antioxidant enzyme systems, and selenium: a review Curr. Med. Chem. 14 2007 1539 1549 (Pubitemid 46902214)
78. W. Verreth, D. De Keyzer, P.C. Davey, B. Geeraert, A. Mertens, M.C. Herregods, G. Smith, F. Desjardins, J.L. Balligand, and P. Holvoet Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice Br. J. Pharmacol. 151 2007 347 355 (Pubitemid 46842672)
79. G. Wang, T. Hamid, R.J. Keith, G. Zhou, C.R. Partridge, X. Xiang, J.R. Kingery, R.K. Lewis, Q. Li, D.G. Rokosh, R. Ford, F.G. Spinale, D.W. Riggs, S. Srivastava, A. Bhatnagar, R. Bolli, and S.D. Prabhu Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart Circulation 121 2010 1912 1925
80. H.D. Wang, P.J. Pagano, Y. Du, A.J. Cayatte, M.T. Quinn, P. Brecher, and R.A. Cohen Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide Circ. Res. 82 1998 810 818 (Pubitemid 28185849)
81. Y. Xu, T. Tang, Y. Ding, R. Yao, J. Xie, M. Liao, H. Xiao, Y. Chen, X. Yu, M. Fu, Y. Liao, G. Zhao, and X. Cheng Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction Am. J. Med. Sci. 340 2010 121 127
82. S.F. Yet, R. Tian, M.D. Layne, Z.Y. Wang, K. Maemura, M. Solovyeva, B. Ith, L.G. Melo, L. Zhang, J.S. Ingwall, V.J. Dzau, M.E. Lee, and M.A. Perrella Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice Circ. Res. 89 2001 168 173 (Pubitemid 34135825)
83. G. Zalba, A. Fortuño, J. Orbe, G. San José, M.U. Moreno, M. Belzunce, J.A. Rodriguez, O. Beloqui, J.A. Páramo, and J. Díez Phagocytic NADPH oxidase- dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis Arterioscler. Thromb. Vasc. Biol. 27 2007 587 593
84. G.X. Zhang, X.M. Lu, S. Kimura, and A. Nishiyama Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation Cardiovasc. Res. 76 2007 204 212 (Pubitemid 350198600)
85. Y. Zhang, C.G. Tocchetti, T. Krieg, and A.L. Moens Oxidative and nitrosative stress in the maintenance of myocardial function Free Radic. Biol. Med. 53 2012 1531 1540
86. Zhou, Q., Liao, J.K., Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr. Pharm. Des. 15, pp. 467-478.
87. M.C. Zimmerman, and I.H. Zucker Mitochondrial dysfunction and mitochondrial- produced reactive oxygen species: new targets for neurogenic hypertension? Hypertension 53 2009 112 114
88. N.S. Zinkevich, and D.D. Gutterman ROS-induced ROS release in vascular biology: redox-redox signaling Am. J. Physiol. Heart Circ. Physiol 301 2011 647 653